AGN News and Press, Allergan plc From 02/14/20

DUBLIN , Feb. 14, 2020 /PRNewswire/ -- Ap9 APPENDIX 3 DISCLOSURE FORMS FORM   8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL&...

This is a mid-week update to the Analysts' Corner regular weekly AbbVie Allergan arbitrage updates. This update is to provide details of current arbitrage opportunity in relation to AbbVie (ABBV) and Allergan (AGN) merger. The following tables may usefully be read in conjunction with artic...

Allergan (NYSE: AGN) is continuing its strategy of targeting millennials with its new advertising campaign. In what could be seen as a counterintuitive strategy, the campaign is the latest one for the company's popular Juvederm dermal filler, a product that older customers traditionally use ...

Original Post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

Ahead of the merger awaiting European Union (“EU”) approval for AbbVie ( ABBV ) and Allergan (AGN), both firms reported strong quarterly results. Although AbbVie risks reporting additional costs post merger, strong revenue from the existing pipeline will protect, if not incre...

Humira has been AbbVie 's (NYSE: ABBV) main growth driver for many years, but with the rheumatoid arthritis drug facing stiff competition from biosimilars in Europe, many were quick to write AbbVie's obituary. Because of Humira's declining prospects in international markets, the pharma giant...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Sprint is up more than 60% in premarket trading on reports that its long-awaited merger with T-Mobile (TMUS) will finally be app...

Allergan (NYSE: AGN)  entered 2020 with a lot of momentum. AbbVie 's (NYSE: ABBV) announcement of its plans to acquire Allergan gave the stock a big boost. That news was so great that investors didn't care that Allergan delivered less-than-exciting third-quarter results in November....

Shares of  Allergan   (NYSE: AGN) received a slight bump on Monday morning in response to a fourth-quarter earnings report that exceeded expectations on the top and bottom lines. Shares of AbbVie (NYSE: ABBV) , a larger drugmaker with plans to buy Allergan in the first quarter...

U.S. stock index futures were little changed on Monday as investors assess the economic impact of the coronavirus outbreak in China. Futures for the Dow Jones Industrials dropped 31 points, or 0.1%, early Friday to 29,015. Futures for the S&P 500 sank 1.75 points, or 0.1%, at 3,32...